Splenic pneumocystosis: an atypical presentation of extrapulmonary Pneumocystis infection.
O'Neal
Curtis B
CB
Weill CornellRockefeller/Sloan-Kettering Institutional MD-PhD Program, New York, USA.
Ball
Susan C
SC
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis* / Q000188:drug therapy; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D053626:Atovaquone / Q000627:therapeutic use; D005260:Female; D006678:HIV; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007150:Immunohistochemistry; D010419:Pentamidine / Q000627:therapeutic use; D016720:Pneumocystis Infections / Q000175:diagnosis* / Q000188:drug therapy; D045363:Pneumocystis carinii / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D016133:Polymerase Chain Reaction; D013154:Spleen / Q000382:microbiology / Q000473:pathology; D013158:Splenic Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D019380:Anti-HIV Agents; D000935:Antifungal Agents; D010419:Pentamidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D053626:Atovaquone